PFE - Applied Therapeutics: This Is A Good Entry Point
Today, we will see why March 2020 can be a good entry point for Applied Therapeutics (APLT).
Company overview
Founded in 2016 and headquartered in New York, Applied Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel drug candidates against validated molecular targets in highly underserved indications with no existing therapies. The focus on targeting pathways with known roles in pathogenesis and opting for abbreviated regulatory pathways enables the company to develop drugs quickly at a lower cost.
The company's lead asset, ARI (aldose reductase inhibitor) AT-001 is being evaluated